Long-term effects of the glucocorticoid receptor modulator CORT113176 in murine motoneuron degeneration

Article

Authorship:

MEYER, MARIA ; KRUSE, MARIA SOL ; GARAY, LAURA INES ; LIMA, ANALIA ETHEL ; ROIG, PAULINA ; Hunt, Hazel ; Belanoff, Joseph ; de Kloet, E. Ronald ; GONZALEZ DENISELLE, MARIA CLAUDIA ; DE NICOLA, ALEJANDRO FEDERICO

Date:

2020

Publishing House and Editing Place:

ELSEVIER SCIENCE BV

Magazine:

BRAIN RESEARCH, vol. 1727 (pp. 146551-146551) ELSEVIER SCIENCE BV

Summary

The Wobbler mouse spinal cord shows vacuolated motoneurons, glial reaction, inflammation and abnormal glutamatergic parameters. Wobblers also show deficits of motor performance. These conditions resemble amyotrophic lateral sclerosis (ALS). Wobbler mice also show high levels of corticosterone in blood, adrenals and brain plus adrenal hypertrophy, suggesting that chronically elevated glucocorticoids prime spinal cord neuroinflammation. Therefore, we analyzed if treatment of Wobbler mice with the glucocorticoid receptor (GR) antagonist CORT113176 mitigated the mentioned abnormalities. 30?mg/kg CORT113176 given daily for 3?weeks reduced motoneuron vacuolation, decreased astro and microgliosis, lowered the inflammatory mediators high mobility group box 1 protein (HMGB1), toll-like receptor 4, myeloid differentiation primary response 88 (MyD88), p50 subunit of nuclear factor kappa B (NF?B), tumor necrosis factor (TNF) receptor, and interleukin 18 (IL18) compared to untreated Wobblers. CORT113176 increased the survival signal pAKT (serine-threonine kinase) and decreased the death signal phosphorylated Junk-N-terminal kinase (pJNK), symptomatic of antiapoptosis. There was a moderate positive effect on glutamine synthase and astrocyte glutamate transporters, suggesting decreased glutamate excitotoxicity. In this pre-clinical study, Wobblers receiving CORT113176 showed enhanced resistance to fatigue in the rota rod test and lower forelimb atrophy at weeks 2–3. Therefore, long-term treatment with CORT113176 attenuated degeneration and inflammation, increased motor performance and decreased paw deformity. Antagonism of the GR may be of potential therapeutic value for neurodegenerative diseases.

Key Words

GLUCOCORTICOID RECEPTOR ANTAGONISMMOTOR BEHAVIORAMYOTROPHIC LATERLA SCLEROSISNEUROINFLAMMATIONWOBBLER MOUSE

Download or request the full text:

http://hdl.handle.net/11336/131954